Needham analyst Chris Pierce initiates coverage on CarMax (NYSE:KMX) with a Hold rating.
Nasdaq Grants Advaxis, Inc. an Extension to November 22, 2021, to Regain Compliance with the $1.00 Minimum Bid Price Rule and Complete Merger Transaction with Biosight, Ltd.
Advaxis, Inc. (NASDAQ:ADXS) (“Advaxis” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of proprietary Lm-based antigen delivery products,
